#metabolic-disease

[ follow ]
Fortune
1 week ago
Startup companies

Obesity drugmaker BioAge targets $158 million in IPO

BioAge Labs Inc. is raising up to $157.5 million in its IPO targeting therapies for obesity and metabolic diseases.
The initial price range suggests a company market value of about $587 million.
Key investors include CEO Kristen Fortney and prominent venture capital firms. [ more ]
InsideHook
1 month ago
Medicine

Flying Foxes Might Be Able to Help Humans Treat Diabetes

Flying foxes may help unlock secrets to managing diabetes and related diseases in humans. [ more ]
theconversation.com
8 months ago
Health

Your Body Has Its Own Built-In Ozempic

Wegovy, Ozempic, and Mounjaro are weight loss and diabetes drugs that target regulatory pathways involved in obesity and diabetes.
The body produces natural versions of these drugs, known as incretin hormones, in the gut, and the trillions of gut microbes play a key role in regulating these hormones. [ more ]
[ Load more ]